Financial Statements

Dermapharm Holding SE (DMP.DE)

47.22 €

+0.18 (+0.38%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 17713910126-
Net Income 21086777578
Stock Dividends -1-520-52
Dividend Paid -47-43-41--
Retained Earnings 33817713910126

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 2001338156-
Annual Depreciation 841089851131
Capital Expenditure -61-41-46-26-75
Net PPE 2222001338156

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -2555202266
New Purchases -0-0-60--48
Intangible and Goodwill 2555202266265

Dermapharm Holding SE income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Dermapharm Holding SE FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.